Identifying high-risk medication: a systematic literature review. Saedder EA, Brock B, Nielsen LP, Bonnerup DK, Lisby M. Eur J Clin Pharmacol. 2014 Jun;70(6):637-45. PMID: 24671697. Abstract.

Implementation of a high-alert medication program. Graham S, Clopp MP, Kostek NE, Crawford B. Perm J. 2008 Spring;12(2):15-22.PMID: 21364807. Abstract.

Frequency and Severity of Adverse Drug Events by Medication Classes: The JADE Study. Sakuma M, Kanemoto Y, Furuse A, Bates DW, Morimoto T. J Patient Saf. 2015 Aug 13. PMID: 26273930. Abstract.

High-risk medication use by nursing home residents before and after hospitalization. Stevenson DG, Dusetzina SB, O’Malley AJ, Mitchell SL, Zarowitz BJ, Chernew ME, Newhouse JP, Huskamp HA. Med Care. 2014 Oct;52(10):884-90. PMID: 25185637. Abstract.

Standardizing i.v. infusion concentrations: National survey results. Phillips MS. Am J Health Syst Pharm. 2011 Nov 15;68(22):2176-82. PMID: 22058104. Abstract.

Electronic screening of medical records to detect inpatients at risk of drug-related problems. Roten I, Marty S, Beney J. Pharm World Sci. 2010 Feb;32(1):103-7. PMID: 20012362. Abstract.

Warfarin: a higher “high-risk” medication? Zarowitz BJ. Geriatr Nurs. 2007 Jan-Feb;28(1):17-24. PMID: 17292792. No abstract is available.

Recommendations and Low-Technology Safety Solutions Following Neuromuscular Blocking Agent Incidents. Graudins LV, Downey G, Bui T, Dooley MJ. Jt Comm J Qual Patient Saf. 2016 Feb;42(2):86-91. PMID: 26803037. Abstract.

Characteristics of pediatric chemotherapy medication errors in a national error reporting database. Rinke ML, Shore AD, Morlock L, Hicks RW, Miller MR. Cancer. 2007 Jul 1;110(1):186-95. PMID: 17530619. Abstract.

Drugs associated with adverse events in children and adolescents. Lee WJ, Lee TA, Pickard AS, Caskey RN, Schumock GT. Pharmacotherapy. 2014 Sep;34(9):918-26. PMID: 24990656. Abstract.